ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Manager, Quality Assurance at Tango Therapeutics - ApplyBlast

Manager, Quality Assurance

Tango Therapeutics

1 month ago

3.7 on Glassdoor

Boston, Massachusetts, United States

Onsite

Full Time

Manager

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Manager, Quality Assurance provides GMP QA oversight for CMC development programs and clinical supply activities, ensuring compliance with global regulations while supporting the advancement of investigational therapies. This role partners cross-functionally with Technical Operations, Regulatory, and external manufacturing partners to maintain inspection readiness and resolve product quality concerns. The position involves leading strategic QA activities, reviewing batch documentation, and mentoring internal teams on quality practices.

Responsibilities

Provide GMP QA oversight for CMC development programs and clinical supply activities
Review batch documentation and dispositions materials for use in clinical trials
Execute and lead implementation of phase-appropriate quality guidance and approval processes

Skills

Qualifications

Bachelor's Degree in Chemistry, Biology, Engineering or related field

About Tango Therapeutics

tangotx.com

Headquarters

Boston, Massachusetts, United States

Company Size

51-200 employees

Founded

2017

View Profile

Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.